Cross-reactive CD4+ and CD8+ T-cell epitopes from α-CCCs and SARS-CoV-2 that present high similarity and identity are associated with natural protection from symptomatic and fatal infections in unvaccinated COVID-19 patients. This evidence concerns the gene CD4 and COVID-19.